NASDAQ:CTMX

Cytomx Therapeutics Stock Predictions

etoro logo Buy CTMX
*Your capital is at risk
$3.16
-0.290 (-8.41%)
At Close: Jun 02, 2026
Currently predicting for Thu, 4 Jun 2026

CTMX Prediction Chart

CTMX Predictions History

Latest community submissions for CTMX.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 28, 2025 $0.80 +4.47% $0.708 X 86.99% 0
Mar 28, 2025 $0.638 +3.46% $0.628 V 98.45% 1
Mar 28, 2025 $0.630 +2.16% $0.628 V 99.73% 5
Mar 28, 2025 Bullish $0.628 V 1
Mar 18, 2025 Bullish $0.604 X 0
Mar 18, 2025 $0.608 -3.97% $0.604 V 99.32% 4
Mar 18, 2025 $0.649 +2.48% $0.604 X 92.56% 0
Mar 18, 2025 $0.84 +29.31% $0.604 X 60.86% 0
Mar 5, 2025 Bullish $0.615 X 0
Feb 24, 2025 $0.80 +3.17% $0.744 X 91.85% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CTMX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CYTOMX THERAPEUTICS
CytomX Therapeutics
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE